{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:18:44Z","timestamp":1789906724769,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.dsx.2015.09.016","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:11:59Z","timestamp":1444867919000},"page":"S154-S157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"S1","title":["Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15"],"prefix":"10.1016","volume":"10","author":[{"given":"Alexander E.","family":"Berezin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (4)","key":"10.1016\/j.dsx.2015.09.016_bib0250","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics \u2013 2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2015.09.016_bib0255","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv295","article-title":"Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial","author":"Jhund","year":"2015","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.dsx.2015.09.016_bib0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/obr.12292","article-title":"The paradox of obesity cardiomyopathy and the potential for weight loss as a therapy","volume":"16","author":"Rayner","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/j.dsx.2015.09.016_bib0265","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12298","article-title":"Targeting fatty acid metabolism to improve glucose metabolism","author":"Stinkens","year":"2015","journal-title":"Obes Rev"},{"issue":"7","key":"10.1016\/j.dsx.2015.09.016_bib0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001646","article-title":"Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the heart and soul study","volume":"4.","author":"Beatty","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2015.06.048","article-title":"Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease","volume":"242","author":"Barrios","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dsx.2015.09.016_bib0280","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the REACH Registry","author":"Cavender","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.dsx.2015.09.016_bib0285","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/dc14-3008","article-title":"Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes","volume":"38","author":"Grossmann","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2015.09.016_bib0290","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-015-3679-4","article-title":"Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4\/F4 study","author":"Kl\u00fcppelholz","year":"2015","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.dsx.2015.09.016_bib0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/2295333715Y.0000000004","article-title":"Inflammatory markers and cardiometabolic diseases","volume":"70","author":"Esser","year":"2015","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.dsx.2015.09.016_bib0300","doi-asserted-by":"crossref","DOI":"10.2337\/dc15-0169","article-title":"The role of markers of low-grade inflammation for the early time course of glycemic control, glucose disappearance rate, and \u03b2-cell function in recently diagnosed type 1 and type 2 diabetes","author":"Weber","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2015.09.016_bib0305","doi-asserted-by":"crossref","DOI":"10.2337\/dc15-0221","article-title":"High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: the Jackson Heart Study","author":"Effoe","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2015.09.016_bib0310","doi-asserted-by":"crossref","first-page":"e0128987","DOI":"10.1371\/journal.pone.0128987","article-title":"Adipocytokines C-reactive protein, and cardiovascular disease: a population-based prospective study","volume":"10","author":"Seven","year":"2015","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.dsx.2015.09.016_bib0315","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.amjcard.2010.03.018","article-title":"Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the justification for use of statins in prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)","volume":"106","author":"Ridker","year":"2010","journal-title":"Am J Cardiol"},{"issue":"3\u20134","key":"10.1016\/j.dsx.2015.09.016_bib0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1900\/RDS.2014.11.231","article-title":"Alternative medicine in diabetes \u2013 role of angiogenesis, oxidative stress, and chronic inflammation","volume":"11","author":"El-Refaei","year":"2014","journal-title":"Rev Diabet Stud"},{"issue":"4","key":"10.1016\/j.dsx.2015.09.016_bib0325","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cytogfr.2013.05.003","article-title":"The multiple facets of the TGF-\u03b2 family cytokine growth\/differentiation factor-15\/macrophage inhibitory cytokine-1","volume":"24","author":"Unsicker","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0330","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.65.1.2","article-title":"MIC-1 is a novel TGF-\u03b2 superfamily cytokine associated with macrophage activation","volume":"65","author":"Fairlie","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.dsx.2015.09.016_bib0335","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.dsx.2015.09.016_bib0340","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2015.9","article-title":"Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death","author":"Jones","year":"2015","journal-title":"Cell Death Differ"},{"issue":"11","key":"10.1016\/j.dsx.2015.09.016_bib0345","doi-asserted-by":"crossref","first-page":"E2277","DOI":"10.1210\/jc.2014-1598","article-title":"Maturation of growth differentiation factor 15 in human placental trophoblast cells depends on the interaction with Matrix Metalloproteinase-26","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2015.09.016_bib0350","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1038\/srep11235","article-title":"Potent paracrine effects of human induced pluripotent stem cell-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dsx.2015.09.016_bib0355","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000368512","article-title":"Iron status and inflammation in early stages of chronic kidney disease","volume":"40","author":"\u0141ukaszyk","year":"2015","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0360","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4238\/2015.March.27.8","article-title":"Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients","volume":"14","author":"Zhu","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.dsx.2015.09.016_bib0365","doi-asserted-by":"crossref","first-page":"426045","DOI":"10.1155\/2015\/426045","article-title":"Can biomarkers help to diagnose early heart failure with preserved ejection fraction?","volume":"2015","author":"Meluz\u00edn","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.dsx.2015.09.016_bib0370","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2015.03.033","article-title":"Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases","volume":"445","author":"Mueller","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.dsx.2015.09.016_bib0375","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ahj.2015.02.019","article-title":"Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the platelet inhibition and patient outcomes trial","volume":"169","author":"Velders","year":"2015","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2012.10.007","article-title":"Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion","volume":"85","author":"Griner","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.dsx.2015.09.016_bib0385","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00380-013-0337-y","article-title":"Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts","volume":"29","author":"Hanatani","year":"2014","journal-title":"Heart Vessels"},{"issue":"4","key":"10.1016\/j.dsx.2015.09.016_bib0390","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11897-013-0160-x","article-title":"Circulating biomarkers in patients with heart failure and preserved ejection fraction","volume":"10","author":"O\u2019Meara","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.dsx.2015.09.016_bib0395","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-662-45805-1_4","article-title":"Pulmonary hypertension: biomarkers","volume":"218","author":"Rhodes","year":"2013","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"10.1016\/j.dsx.2015.09.016_bib0400","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejim.2011.08.022","article-title":"Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy","volume":"23","author":"Montoro-Garc\u00eda","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dsx.2015.09.016_bib0405","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2015.06.012","article-title":"Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery","volume":"197","author":"Guenancia","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.dsx.2015.09.016_bib0410","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/ehp261","article-title":"Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction disease in the elderly: results from the prospective investigation of the vasculature in uppsala seniors (PIVUS) study","volume":"30","author":"Lind","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2015.09.016_bib0415","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-12-0466","article-title":"Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial","volume":"167","author":"Kempf","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.diabres.2015.05.001","article-title":"Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment","volume":"109","author":"Hong","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.dsx.2015.09.016_bib0425","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.dsx.2015.09.016_bib0430","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2014.06.020","article-title":"Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus","volume":"114","author":"Dominguez-Rodriguez","year":"2014","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0435","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1373\/clinchem.2011.171926","article-title":"Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study","volume":"58","author":"Rohatgi","year":"2012","journal-title":"Clin Chem"},{"issue":"13","key":"10.1016\/j.dsx.2015.09.016_bib0440","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/hrt.2011.224857","article-title":"Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension","volume":"97","author":"Rhodes","year":"2011","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.dsx.2015.09.016_bib0445","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2015.09.016_bib0450","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehm465","article-title":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction","volume":"28","author":"Kempf","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2015.09.016_bib0455","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study","volume":"2","author":"Kempf","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.dsx.2015.09.016_bib0460","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehp300","article-title":"Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy","volume":"30","author":"Foley","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2015.09.016_bib0465","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2015-307742","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement","author":"Lindman","year":"2015","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.dsx.2015.09.016_bib0470","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/ATVBAHA.110.213512","article-title":"Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22","volume":"31","author":"Bonaca","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.dsx.2015.09.016_bib0475","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1530\/EJE-09-1066","article-title":"Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study","volume":"162","author":"Carstensen","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.dsx.2015.09.016_bib0480","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.atherosclerosis.2015.02.017","article-title":"Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease","volume":"239","author":"Cavusoglu","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.dsx.2015.09.016_bib0485","first-page":"387","article-title":"Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy","volume":"34","author":"Li","year":"2014","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"10.1016\/j.dsx.2015.09.016_bib0490","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MAJ.0b013e318291cd4e","article-title":"Growth-differentiation factor-15 and major cardiac events","volume":"347","author":"Lin","year":"2014","journal-title":"Am J Med Sci"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115300217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115300217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T11:29:40Z","timestamp":1567250980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402115300217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1871402115300217"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2015.09.016","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2015.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}